With over 0.15 million Quipt Home Medical Corp. (QIPT) shares trading Friday and a closing price of $6.04 on the day, the dollar volume was approximately $0.91 million. The shares have shown a positive half year performance of 11.03% and its price on 01/20/23 gained nearly 4.14%. Currently, there are 34.24M common shares owned by the public and among those 33.31M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 10 analysts who have offered their price forecasts for QIPT have a consensus price objective of $10.51. The analysts have set the share’s price value over the next 12 months at a high of $13.71 and a low of $8.69. The average price target is 34.13% above its recent price level and an upside to the estimated low will see the stock gain 30.49% over that period. But an upside of 55.94% will see the stock hit the forecast high price target while median target price for the stock is $10.17.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in Quipt Home Medical Corp. are Valentum, FI, Berenberg International Micro Cap, and Russell Investment Co. – US Small. Valentum, FI owns 0.54 million shares of the company’s stock, all valued at over $2.55 million. The company bought an additional 1237.0 shares recently to bring their total holdings to about 1.52% of the shares outstanding. Berenberg International Micro Cap sold 99556.0 shares to see its total holdings shrink to 0.34 million shares valued at over $1.59 million and representing 0.95% of the shares outstanding. Russell Investment Co. – US Small bought 62079.0 shares to bring its total holdings to over 0.26 million shares at a value of $1.2 million. Russell Investment Co. – US Small now owns shares totaling to 0.72% of the shares outstanding.
Shares of Quipt Home Medical Corp. (NASDAQ: QIPT) opened at $5.82, up $0.02 from a prior closing price of $5.80. However, the script later moved the day high at 6.06, up 4.14%. The company’s stock has a 5-day price change of 4.32% and 51.38% over the past three months. QIPT shares are trading 28.24% year to date (YTD), with the 12-month market performance up to 4.86% higher. It has a 12-month low price of $3.89 and touched a high of $5.94 over the same period. QIPT has an average intraday trading volume of 41.71K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 16.10%, 27.03%, and 28.14% respectively.
Institutional ownership of Quipt Home Medical Corp. (NASDAQ: QIPT) shares accounts for 29.45% of the company’s 34.24M shares outstanding. Mutual fund holders own –, while other institutional holders and individual stakeholders account for — and — respectively.
It has a market capitalization of $276.39M and a beta (3y monthly) value of 1.60. The stock’s trailing 12-month PE ratio is 33.56, while the earnings-per-share (ttm) stands at $0.18. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.54% over the week and 5.58% over the month.
Analysts forecast that Quipt Home Medical Corp. (QIPT) will achieve an EPS of $0.02 for the current quarter, $0.04 for the next quarter and $0.18 for 2023. The lowest estimate earnings-per-share for the quarter is $0.02 while analysts give the company a high EPS estimate of $0.02. Comparatively, EPS for the current quarter was -$0.04 a year ago. Earnings per share for the fiscal year are expected to increase by 165.70%, and 300.00% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 10 brokerage firm advisors rate Quipt Home Medical Corp. (QIPT) as a “Moderate Buy” at a consensus score of 2.00. Specifically, 9 Wall Street analysts polled rate the stock as a buy, while 0 of the 10 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the QIPT, a number of firms have released research notes about the stock. The Benchmark Company stated their Buy rating for the stock in a research note on October 20, 2021, with the firm’s price target at $7.50.